Related Experiment Videos
Actual data on efficacy of surgical adjuvant chemotherapy with CMF in breast cancer
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Expression in murine and human neuroblastoma cell lines of VGF, a tissue specific protein.
International journal of developmental neuroscience : the official journal of the International Society for Developmental Neuroscience·1992
Supraspinal influences on recurrent inhibition in humans. Paralysis of descending control of Renshaw cells in patients with mental retardation.
Electroencephalography and clinical neurophysiology·1992
Dietary fructose enhances the development of atypical acinar cell nodules in the pancreas of rats pretreated with N-nitrosomorpholine.
Archiv fur Geschwulstforschung·1990
[The influence of macrophages on the leukemogenic activity of Rauscher murine leukemia virus].
Archiv fur Geschwulstforschung·1990
Transfection by DNA-nuclear protein HMG1 complexes: raising of efficiency and role of DNA topology.
Archiv fur Geschwulstforschung·1990
[Attempts at analyzing the initiation of the initial processes of carcinogenesis based on the Xiphophorus melanoma model].
Archiv fur Geschwulstforschung·1990
Primary prevention of cancer: priorities for practical implementation and research.
Archiv fur Geschwulstforschung·1990
A case of gonadoblastoma in a normal woman with tubal pregnancy.
Archiv fur Geschwulstforschung·1990
Time to Treatment Failure as a Recorded Treatment-Process Measure in C-CAT. Reply to Comment on "Facility-Level Medical Oncology Specialist Availability and First-Line Time to Treatment Failure in Lung Cancer: A Nationwide C-CAT Registry Analysis. Curr. Oncol. 2026, 33, 462".
Current oncology (Toronto, Ont.)·2026
Does Time to Treatment Failure Measure the Same Clinical Process Across Oncology Facilities? Comment on Kajiura et al. Facility-Level Medical Oncology Specialist Availability and First-Line Time to Treatment Failure in Lung Cancer: A Nationwide C-CAT Registry Analysis. Curr. Oncol. 2026, 33, 462.
Current oncology (Toronto, Ont.)·2026
[177Lu]Lu-PSMA-617 in Metastatic Hormone-Sensitive Prostate Cancer: Evidence from PSMAddition and Considerations for Treatment Sequencing.
Current oncology (Toronto, Ont.)·2026
A New Era of Treatment Sequencing in Platinum-Resistant Ovarian Cancer: Integrating Immunotherapy, Antibody-Drug Conjugates, and Targeted Therapies.
Current oncology (Toronto, Ont.)·2026